These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19169900)

  • 1. Mycophenolate mofetil for the treatment of autoimmune diseases: hype or hope?
    Daikeler T
    Swiss Med Wkly; 2009 Jan; 139(3-4):34. PubMed ID: 19169900
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mycophenolate mofetil: a new immunosuppressive drug in dermatology and its possible uses].
    Geilen CC; Orfanos-Boeckel H; Offermann G; Orfanos CE
    Hautarzt; 2000 Feb; 51(2):63-9. PubMed ID: 10743574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolate mofetil prevents development of urinary protein in autoimmune nephritis.
    Takeda S; Takahashi M; Kusano E; Kobayashi E
    Kidney Int; 2003 Jul; 64(1):365-6; author reply 366. PubMed ID: 12787433
    [No Abstract]   [Full Text] [Related]  

  • 4. Mycophenolate mofetil monotherapy for pemphigus vulgaris.
    Bredlich RO; Grundmann-Kollmann M; Behrens S; Kerscher M; Peter RU
    Br J Dermatol; 1999 Nov; 141(5):934. PubMed ID: 10583186
    [No Abstract]   [Full Text] [Related]  

  • 5. Mycophenolate mofetil, Cellcept, a new immunosuppressive drug with great potential in internal medicine.
    Smak Gregoor PJ; van Gelder T; Weimar W
    Neth J Med; 2000 Dec; 57(6):233-46. PubMed ID: 11099793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of remission in a child with autoimmune enteropathy using mycophenolate mofetil.
    Quirós-Tejeira RE; Ament ME; Vargas JH
    J Pediatr Gastroenterol Nutr; 2003 Apr; 36(4):482-5. PubMed ID: 12658040
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of rheumatic diseases: current status and future prospective. Topics: II. Immunosuppressant/antirheumatic drugs: 9. Mycophenolate mofetil].
    Kono M; Atsumi T
    Nihon Naika Gakkai Zasshi; 2011 Oct; 100(10):2954-9. PubMed ID: 22175137
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful treatment of linear IgA disease with mycophenolate mofetil as a corticosteroid sparing agent.
    Talhari C; Mahnke N; Ruzicka T; Megahed M
    Clin Exp Dermatol; 2005 May; 30(3):297-8. PubMed ID: 15807696
    [No Abstract]   [Full Text] [Related]  

  • 9. Mycophenolate mofetil: new applications for this immunosuppressant.
    Moder KG
    Ann Allergy Asthma Immunol; 2003 Jan; 90(1):15-19; quiz 20, 78. PubMed ID: 12546332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of Cogan's syndrome resolved with mycophenolate sodium.
    Di Leo E; Dambra PP; Capuzzimati L; Giovine A; Guerriero S; Nettis E; Vacca A
    Eur J Clin Invest; 2008 Aug; 38(8):605. PubMed ID: 18717829
    [No Abstract]   [Full Text] [Related]  

  • 11. Mycophenolate mofetil in animal models of autoimmune disease.
    Zandman-Goddard G; Shoenfeld Y
    Lupus; 2005; 14 Suppl 1():s12-6. PubMed ID: 15803926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil: what is its place in the treatment of autoimmune rheumatic diseases?
    Iaccarino L; Rampudda M; Canova M; Della Libera S; Sarzi-Puttinic P; Doria A
    Autoimmun Rev; 2007 Jan; 6(3):190-5. PubMed ID: 17289556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil for the management of autoimmune bullous diseases.
    Eskin-Schwartz M; David M; Mimouni D
    Dermatol Clin; 2011 Oct; 29(4):555-9. PubMed ID: 21924997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolate mofetil for maintenance of remission in steroid-dependent autoimmune pancreatitis.
    Sodikoff JB; Keilin SA; Cai Q; Bharmal SJ; Lewis MM; Raju GS; Willingham FF
    World J Gastroenterol; 2012 May; 18(18):2287-90. PubMed ID: 22611324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-transplant uses of mycophenolate mofetil.
    Jayne D
    Curr Opin Nephrol Hypertens; 1999 Sep; 8(5):563-7. PubMed ID: 10541218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of mycophenolate mofetil for the treatment of autoimmune and chronic idiopathic urticaria: experience in 19 patients.
    Zimmerman AB; Berger EM; Elmariah SB; Soter NA
    J Am Acad Dermatol; 2012 May; 66(5):767-70. PubMed ID: 21783274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil, Crohn's disease, measles?
    Altschuler EL
    Am J Gastroenterol; 2000 Feb; 95(2):550-1. PubMed ID: 10685769
    [No Abstract]   [Full Text] [Related]  

  • 18. Mycophenolate mofetil treatment in conditions different from organ transplantation.
    Quiroz Y; Herrera-Acosta J; Johnson RJ; Rodriguez-Iturbe B
    Transplant Proc; 2002 Nov; 34(7):2523-6. PubMed ID: 12431510
    [No Abstract]   [Full Text] [Related]  

  • 19. Pemphigus foliaceus successfully treated with mycophenolate mofetil as a steroid-sparing agent.
    Katz KH; Marks JG; Helm KF
    J Am Acad Dermatol; 2000 Mar; 42(3):514-5. PubMed ID: 10688729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome.
    Rao VK; Dugan F; Dale JK; Davis J; Tretler J; Hurley JK; Fleisher T; Puck J; Straus SE
    Br J Haematol; 2005 May; 129(4):534-8. PubMed ID: 15877736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.